A Brief History of Genetic Vaccines (Part 1): Ebola

By Julie Beal

Most of the coronavirus vaccines are genetic potions of one kind or another, and so much time and money has gone into them, it seems a return on investment is now due. Genetic vaccines are part of a huge industry based on synthetic versions of natural biology, with many prepped and ready to go.

Tracing back the history of DNA vaccines for HIV and Ebola begins to shed some light on how the coronavirus vaccines came into being. This article (Part 1) is about DNA vaccines for Ebola, e.g. trials in Africa that used contact tracing, and where people felt like lab rats, vaccine ingredients and genetic contaminants. Part 2 will trace the endless failures of DNA vaccines for HIV over the last 30 years, and look at how HIV brought in the concept of testing for ‘cases of suspected infection’.

(See link for article)



Important quote:

Originally with the catchy name ‘rVSV-ZEBOV’, the vaccine uses the vesicular stomatitis virus (VSV) as a way to get the fake DNA version of Ebola inside the cells of the body. The VSV is recombinant (genetically engineered) and becomes a hybrid because it’s got some genetic code hidden inside it that says “Make Ebola proteins!”  This is supposed to mimic a natural infection, and the body is supposed to understand the man-made code and react accordingly. The same method is being used by several other companies for all sorts of ‘viral infections’; most notably, the ronavax made by AstraZeneca and J&J, both of which use adenoviruses to carry the code for coronavirus proteins. However, unlike the viral vectors used for the ronavax, this one is replication competent, meaning it’s able to multiply inside the person who’s been vaccinated.

The scary part is, like other vaccines for viruses, the vaccinated can shed the virus and spread it to others.

Vaccine virus RNA has been detected in blood, saliva, urine, and fluid from skin vesicles of vaccinated adults; transmission of vaccine virus is a theoretical possibility.”

Adverse reactions from the Ebola vaccine:

  • injection-site pain (70%)
  • headache (37%)
  • feverishness (34%)
  • muscle pain (33%)
  • fatigue (19%)
  • joint pain (18%)
  • swelling (17%)
  • redness (12%)
  • nausea (8%)
  • arthritis (5%)
  • rash (4%)
  • abnormal sweating (3%)

But people also reported chills, paraesthesia, anaphylaxis, serious pyrexia reaction, severe arthritis and severe arthralgia. Some had “recurrent or prolonged joint symptoms lasting up to 2 years following vaccination.  Somehad cutaneous vasculitis, and rash, which seems to indicate viral shedding. Up to 85% of them had decreases in lymphocytes, while 43% had decreases in neutrophils.

But the scariest part is that no tests for genetic toxicity are required for genetic vaccines because they are considered to be ‘biologics.’

It may cause problems with pregnancy and it may well be in breast milk.

The murkiness surrounding vaccine development is prolific:

%d bloggers like this: